share_log

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Leschly Nick

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Leschly Nick

bluebird bio | 4:持股变动声明-董事 Leschly Nick
美股SEC公告 ·  2024/11/09 05:17

Moomoo AI 已提取核心信息

On November 6, 2024, Nick Leschly, associated with bluebird bio, Inc. [BLUE], completed a transaction involving the direct acquisition of 24,900 shares of common stock at no cost. Following this transaction, Leschly's direct holdings in the company increased to a total of 315,839 shares. Additionally, Leschly holds an indirect interest in 168,699 shares through entities such as the Nick Leschly 2001 Trust and the Nick Leschly Irrevocable GST Trust of 2019. The nature of the transaction was classified as a grant, which typically indicates an award or acquisition related to compensation or incentive programs.
On November 6, 2024, Nick Leschly, associated with bluebird bio, Inc. [BLUE], completed a transaction involving the direct acquisition of 24,900 shares of common stock at no cost. Following this transaction, Leschly's direct holdings in the company increased to a total of 315,839 shares. Additionally, Leschly holds an indirect interest in 168,699 shares through entities such as the Nick Leschly 2001 Trust and the Nick Leschly Irrevocable GST Trust of 2019. The nature of the transaction was classified as a grant, which typically indicates an award or acquisition related to compensation or incentive programs.
2024年11月6日,与蓝鸟生物公司[BLUE]有关的尼克·莱什利(Nick Leschly)完成了一项交易,直接收购了24,900股普通股,不收取任何费用。在此次交易之后,莱什利在该公司的直接持股总数增至315,839股。此外,莱什利通过尼克莱什利2001信托基金和尼克莱什利2019不可撤销GSt信托等实体持有168,699股的间接利益。交易性质被归类为补助,通常表明与薪酬或激励计划相关的奖励或收购。
2024年11月6日,与蓝鸟生物公司[BLUE]有关的尼克·莱什利(Nick Leschly)完成了一项交易,直接收购了24,900股普通股,不收取任何费用。在此次交易之后,莱什利在该公司的直接持股总数增至315,839股。此外,莱什利通过尼克莱什利2001信托基金和尼克莱什利2019不可撤销GSt信托等实体持有168,699股的间接利益。交易性质被归类为补助,通常表明与薪酬或激励计划相关的奖励或收购。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息